At the end of the latest market close, Rhythm Pharmaceuticals Inc. (RYTM) was valued at $24.43. The stock current value is $24.97.Recently in News on November 21, 2022, Rhythm Pharmaceuticals Announces ▼IMCIVREE® (setmelanotide) Granted Marketing Authorization in Great Britain for Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome. — Health Canada accepts for review new drug submission for setmelanotide for the treatment of obesity and control of hunger in BBS and biallelic POMC, PCSK1 and LEPR deficiencies –. You can read further details here
Rhythm Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $30.98 on 09/14/22, with the lowest value was $3.04 for the same time period, recorded on 05/20/22.
Rhythm Pharmaceuticals Inc. (RYTM) full year performance was 150.45%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Rhythm Pharmaceuticals Inc. shares are logging -19.40% during the 52-week period from high price, and 721.38% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.04 and $30.98.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 368962 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Rhythm Pharmaceuticals Inc. (RYTM) recorded performance in the market was 150.20%, having the revenues showcasing 4.83% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.28B, as it employees total of 140 workers.
The Analysts eye on Rhythm Pharmaceuticals Inc. (RYTM)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 21.03, with a change in the price was noted +20.57. In a similar fashion, Rhythm Pharmaceuticals Inc. posted a movement of +467.50% for the period of last 100 days, recording 1,840,476 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for RYTM is recording 0.26 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.26.
Technical rundown of Rhythm Pharmaceuticals Inc. (RYTM)
Raw Stochastic average of Rhythm Pharmaceuticals Inc. in the period of last 50 days is set at 55.74%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 49.71%. In the last 20 days, the company’s Stochastic %K was 38.99% and its Stochastic %D was recorded 39.34%.
Considering, the past performance of Rhythm Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 150.20%. Additionally, trading for the stock in the period of the last six months notably improved by 668.31%, alongside a boost of 150.45% for the period of the last 12 months. The shares increased approximately by -2.50% in the 7-day charts and went down by 2.67% in the period of the last 30 days. Common stock shares were driven by 4.83% during last recorded quarter.